Procurement Summary
Country: USA
Summary: Sole Source Production of Chadox1 and Mva Expressing Mouse Gp70
Deadline: 24 Aug 2026
Posting Date: 18 Aug 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 147434937
Document Ref. No.: 75N98026Q00996
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Title: Production of ChAdOx-1 and MVA expressing mouse gp70
Document type: Combined Synopsis/Intent to Sole Source
Solicitation Number: RFQ# 75N98026Q00996
Proposed Post Date: 08/12/2026
Proposed Response Date: 08/19/2026
NAICS Code: 541714
Small Business Size Standard: 1, 000
Contracting Office Address: Department of Health and Human Services, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20817 USA.
Description:
The National Cancer Center-s (NCI) Laboratory of Integrative Cancer Immunology Branch / The Immune Regulation and Vaccine Development Section intends to award a sole-source purchase order using the procedures at FAR 13.106-1(b)(1), as it has been deemed that only one source is available to meet this specific requirement to provide service of producing chimpanzee adenovirus (ChAdOx-1) vectors and MVA viral vector expressing mouse gp70. This purchase order is intended to be awarded to Viral Vector Core at the Pandemic Institute, University of Oxford, Pandemic Science Institute - University of Oxford Old Road Campus Research Building (ORCRB), Oxford, OX3 7DQ, Oxford, OX3 7DQ. The requirements document in the form of a Statement of Work is attached to this notice.
The acquisition will be processed in accordance with Sole Source Selection procedures as stated in FAR Part 6.302-1 and 41 U.S.C. 3304(a)(1and is exempt from the requirements of FAR Part 6. The North American Industry Classification System code is 541714 “Research and Development in Biotechnology (except Nanobiotechnology)” and the business size standard is 1, 000 employees.
In the development of a vaccine for glioblastoma, a high-grade brain tumor, there has been use of a combination of ChAdOx and MVA in syngeneic orthotopic mouse glioblastoma models. This has demonstrated this combination significantly prolongs the survival of tumor-bearing animals by inducing a robust population of tumor-specific CD8 T cells in the brain. The selection of this set ...
Notice ID: 75n98026q00996
Department/Ind. Agency: health and human services, department of
Sub-tier: national institutes of health
Office: nih nci
Product Service Code: r416 - support- professional: veterinary/animal care
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Inactive Dates: sep 08, 2026
Inactive Policy: 15 days after date offers due
Documents
Tender Notice
Documents.zip